Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
559,404
+179,150
+47% +$356K ﹤0.01% 3513
2026
Q1
$597K Sell
380,254
-2,898
-0.8% -$5.23K ﹤0.01% 3760
2025
Q4
$709K Buy
383,152
+196,871
+106% +$342K ﹤0.01% 3743
2025
Q3
$298K Buy
+186,281
New +$340K ﹤0.01% 4117
2024
Q3
Sell
-42,963
Closed -$161K 4772
2024
Q2
$161K Sell
42,963
-77,704
-64% -$354K ﹤0.01% 4114
2024
Q1
$654K Sell
120,667
-127,445
-51% -$734K ﹤0.01% 3351
2023
Q4
$1.53M Buy
248,112
+42,325
+21% +$208K ﹤0.01% 2861
2023
Q3
$1.07M Buy
205,787
+111,294
+118% +$594K ﹤0.01% 3018
2023
Q2
$475K Buy
+94,493
New +$383K ﹤0.01% 3443
2022
Q4
Sell
-702,724
Closed -$7.17M 5032
2022
Q3
$7.17M Buy
702,724
+250,000
+55% +$2.54M 0.01% 1693
2022
Q2
$4.58M Hold
452,724
0.01% 2234
2022
Q1
$4.58M Buy
452,724
+119,238
+36% +$1.19M ﹤0.01% 2418
2021
Q4
$3.32M Buy
+333,486
New +$3.33M ﹤0.01% 2835

Other funds holding OABI

David Shaw's OABI Position: Q2 2026 in Review

David Shaw increased its OmniAb (OABI) stake by 47% in Q2 2026, buying an estimated $356K and bringing the position to 559,404 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

David Shaw first reported a position in OABI in Q4 2021 and has held it in 13 quarters since. The position peaked at $7.17M in Q3 2022. 130 funds tracked by Wall St. Rank hold OABI as of Q2 2026.

  • David Shaw held 559,404 shares of OmniAb worth $1.38M as of Q2 2026.
  • David Shaw bought 179,150 OmniAb shares in Q2 2026, an estimated $356K.
  • OmniAb made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3513 holding.
  • David Shaw first reported a position in OmniAb in Q4 2021 and has held it in 13 quarters since.
  • David Shaw's OmniAb position peaked at $7.17M in Q3 2022.
  • 130 funds tracked by Wall St. Rank held OmniAb as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.